Relay Therapeutics (RLAY) Preferred Stock Liabilities (2020)
Relay Therapeutics (RLAY) has disclosed Preferred Stock Liabilities for 1 consecutive years, with $537.8 million as the latest value for Q2 2020.
Relay Therapeutics (RLAY) has disclosed Preferred Stock Liabilities for 1 consecutive years, with $537.8 million as the latest value for Q2 2020.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month